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Background: The Schmallenberg virus (SBV) emerged in Europe in 2011 and caused a widespread epidemic in
ruminants.
In France, SBV emergence was monitored through a national multi-stakeholder surveillance and investigation system.
Based on the monitoring data collected from January 2012 to August 2013, we describe the spread of SBV in France
during two seasons of dissemination (vector seasons 2011 and 2012) and we provide a large-scale assessment of the
impact of this new disease in ruminants.
Results: SBV impact in infected herds was primarily due to the birth of stillborns or deformed foetuses and neonates.
Congenital SBV morbidity level was on average moderate, although higher in sheep than in other ruminant species.
On average, 8% of lambs, 3% of calves and 2% of kids born in SBV-infected herds showed typical congenital SBV
deformities. In addition, in infected herds, farmers reported retrospectively a lower prolificacy during the vector
season, suggesting a potential impact of acute SBV infection during mating and early stages of gestation.
Conclusions: Due to the lack of available control and prevention measures, SBV spread quickly in the naive ruminant
population. France continues to monitor for SBV, and updated information is made available online on a regular basis
[http://www.plateforme-esa.fr/]. Outbreaks of congenital SBV are expected to occur sporadically from now on, but
further epidemics may also occur if immunity at population level declines.
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In the autumn of 2011, a previously unknown virus infect-
ing ruminants named "Schmallenberg" virus (SBV) was
identified in dairy cows, in the eastern regions of the
Netherlands and in north-western Germany [1,2]. This
virus belongs to the Simbu serogroup of the genus
Orthobunyavirus of the family Orthobunyaviridae. Like
other orthobunyaviruses, it is transmitted by arthropod
vectors, primarily by biting midges (Culicoides spp). In
areas with a temperate climate, this leads to a seasonal
pattern of spread (summer and autumn) ([3,4]). Acute
SBV infection in adult ruminants has been reported either
to cause a mild and transient disease (fever, drop in milk* Correspondence: morgane.dominguez@anses.fr
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article, unless otherwise stated.production, diarrhoea in cattle) or to remain clinically un-
apparent [1,5].
In pregnant ruminants, transplacental SBV infection
during a delimited stage of gestation can lead to the birth
of severely deformed offspring (i.e. arthrogryposis, stiff
neck, brachygnathia, hydranencephaly and other severe
brain malformations) ([3,6]). The type of malformation
typically caused by viruses of the Simbu serogroup is
referred to as “arthrogryposis hydranencephaly syndrome”
(AHS) [7,8].
Due to the lack of SBV-specific knowledge, it has been
assumed by analogy to Akabane virus (another virus of
the Simbu serogroup) that the vulnerable stage of gesta-
tion, when SBV foetal infection could lead to AHS, is the
second month of gestation for small ruminants (i.e. three
to four months before lambing) and between the third andntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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months before calving) [9-11].
AHS in ruminant offspring due to SBV foetal infections
was first reported in Europe during the winter of 2011–
2012. As of April 2013, according to the European Food
Safety Agency (EFSA), SBV infections had been confirmed
in about 9,000 ruminant herds across Europe, and about
half of those were reported in France [12].
We present the spatial and temporal patterns of SBV
emergence in France. Additionally, we assess the impact
of SBV infection within the infected herds.
Methods
National framework for emerging animal disease surveillance
Detecting and responding to disease emergence requires
robust human and technical capability, capacity and re-
sources. In France, emerging animal disease surveillance
and investigation is facilitated through the French platform
for epidemiological surveillance in animal health (ESA
Platform), which was launched at the end of 2011 to
reinforce animal disease monitoring. This platform is
coordinated by the French Ministry of Agriculture and
involves various animal health stakeholders: national
reference laboratories of the French Agency for Food,Figure 1 National multi-stakeholder SBV surveillance and investiga
August 2012).Environmental and Occupational Health & Safety (ANSES),
laboratories (ADILVA, local diagnostic laboratories),
livestock organisations (GDS France, Coop de France), a
veterinary organisation (SNGTV), an international research
centre (Cirad), and wildlife and hunting organisations (FNC
and ONCFS).
The ESA Platform is a collaboration framework aiming
at improving animal health by supporting the surveillance
of established diseases and ensuring the timely detection
and effective monitoring and investigation of emerging
diseases [13].
SBV emergence surveillance and investigation system
Since December 2011, following a European alert of the
emergence of AHS in ruminants due to SBV infection
[14], the ESA Platform has been coordinating the moni-
toring and investigation of SBV emergence in France. At
the onset of the epidemic (from January 2012), the mon-
itoring aimed at assessing the disease situation and provid-
ing knowledge on its impact within the infected herds
(Figure 1). Then, from September 2012, the level of con-
cern about the SBV disease decreased but the monitoring
was continued to keep track of trends in the epidemic
(Figure 2).tion system during the initial stage of alert (France, January –
Figure 2 Simplified national multi-stakeholder SBV surveillance system during the second stage of alert (France, September 2012 – August
2013).
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of AHS in ruminants and in-herd impact investigations
Surveillance of congenital SBV
A “congenital SBV-infected herd” was defined as any
ruminant herd with one or more ruminant neonate(s) or
foetus(es) showing AHS with a laboratory confirmation
of SBV infection.
A national event-based SBV surveillance system based
on the mandatory notification of clinical suspicions of
AHS in ruminants, coordinated by the Ministry of Agricul-
ture in the framework of the ESA Platform, was launched
in early January 2012 to help detect a potential introduc-
tion of the virus to France. After the first detection of con-
genital SBV-infected herds, this surveillance was continued
to further assess the spread of the disease [15] (Figure 1).
Farmers were urged to contact their veterinarian when
encountering cases of ruminant neonates or foetuses
showing AHS. Veterinarians reported suspected cases to
the local veterinary services and collected samples for
laboratory confirmation of SBV infection. The costs of
the veterinarian’s visit and laboratory tests were covered
by the government.
SBV diagnosis was performed in national and local
reference laboratories. From January to April 2012,
SBV infection was confirmed by real-time reverse tran-
scriptase polymerase chain reaction (rtRT-PCR) [1,16],
preferentially from offsprings’ brain samples. Upon
April 2012, ELISA kits were made available and SBV
infection was confirmed by ELISA, preferentially from
offsprings’ blood samples collected before colostrum
intake [17].The laboratory results were transmitted to the Ministry
of Agriculture, which keeps records at the national level of
congenital SBV-infected herds.
In-herd impact investigations
Complementary to the surveillance, a national survey was
launched to provide an estimate of the impact of the dis-
ease in congenital SBV-infected herds (Figure 1). Agents of
local animal health farmers' organisations (local GDS) vis-
ited the congenital SBV-infected herds identified through
the surveillance programme to investigate the impact
of the disease according to a standardised investigation
questionnaire.
In the herds where births were grouped (e.g. hormonal
synchronisation of the oestrous cycle), the impact assess-
ment took into account the births from the beginning of
the birth period to the time when the investigation was
performed. In herds where the births were not grouped
(i.e. some of the beef cattle herds), the impact assessment
considered births from three months before the first
observation of AHS in that herd to the time when the
investigation was performed. The total number of off-
spring born in congenital SBV affected herds over these
periods was recorded by the farmer, as well as the total
number of offspring showing various defects (e.g. stillborn
or deformed), and among them the number of offspring
showing AHS. The types of congenital deformity encoun-
tered in the defective offspring were also recorded [18].
At the beginning of the epidemic, any congenital SBV-
infected herd identified through surveillance was investi-
gated, provided that the farmer’s agreement was obtained.
Table 1 Number of congenital SBV-infected herds reported
by species (France, January 2012 – August 2013)








1In France (mainland and Corsica).
2With cows older than 24 months - ewes older than 12 months - goats older
than 12 months.
Dominguez et al. BMC Veterinary Research 2014, 10:248 Page 4 of 10
http://www.biomedcentral.com/1746-6148/10/248Then, when more than 30 investigations had been per-
formed for a species in a given département (French ad-
ministrative unit with a mean area of 5,800 km2), only the
first in every five congenital SBV-infected herds were in-
vestigated. The investigation results were entered by the
agents of the local GDS into a national web-based data-
base. The centralised data was analysed jointly by the na-
tional animal health farmers’ organisation (GDS-France)
and ANSES.
Second stage - decreased level of alert: voluntary reporting
of AHS in ruminants
In spring 2012, congenital SBV was declared a non-priority
disease by both the World Organization for Animal Health
[19] and the European Union, so the level of alert for SBV
was lowered. Subsequently, the French Ministry of Agricul-
ture disengaged from the coordination of SBV monitoring.
From September 2012, in the framework of the ESA Plat-
form, GDS France took over the coordination of a reduced
SBV monitoring system aiming at keeping track of trends
in the epidemic (Figure 2).
Notifying clinical suspicions of AHS in ruminant neonate
(s) or foetus(es) was no longer compulsory, but farmers
were strongly encouraged to report any suspicion to their
veterinarian. Veterinarians were then asked to report
suspected cases to the local GDS and to collect samples
for laboratory confirmation. The costs of the veterinarian’s
visit and sampling were covered by the government in the
framework of the national scheme for abortion surveil-
lance. However, unless specific local agreements had been
defined, the laboratory costs for SBV confirmation were in-
curred by the farmers.
SBV infection was confirmed in local diagnostic labora-
tories, preferentially by ELISA performed on offsprings’
blood samples collected before colostrum intake. The
data collected by the veterinarians in the herds and the
SBV laboratory results were entered by GDS agents into a
national web-based database. The centralised data was
analysed by GDS France.
No specific in-herd impact investigation was performed
upon confirmation of infection. However, the data collected
by the veterinarians when notifying the suspicion did in-
clude a description of the type of congenital deformities ob-
served and also, in order to explore potential consequences
of acute SBV infection during the early stages of gestation,
a retrospective farmer’s statement on the occurrence of re-
peated oestrus or early embryonic deaths during the previ-
ous vector season.
Description of the spread and impact of the SBV
epidemic in France in 2012–2013
To describe the spread and impact of the SBV epidemic in
France in 2012–2013, we analysed the data collected from
January 2012 to August 2013 through the two consecutiveSBV surveillance and investigation systems. The dataset
was based upon data collected from January 2012 to
August 2012 through the mandatory reporting of AHS
in ruminants and the impact investigation in the affected
herds, and the data collected from September 2012 to
August 2013 through the voluntary reporting of AHS
in ruminants.
Dataset quality was checked for completeness. Duplicates
were eliminated using the national herd identification num-
bers. Only the herds for which a laboratory confirmation
for SBV infection was duly recorded were considered as
congenital SBV-infected herds.
The dataset was used to compute indicators on the
spread of SBV, both temporally (by calculating the number
of congenital SBV-infected herds reported by month, from
January 2012 to August 2013 – using the date of notifica-
tion of the clinical suspicion of congenital SBV by the
veterinarian), and spatially (by calculating the number
of congenital SBV-infected herds reported by Region –
i.e. French administrative units corresponding to level 2
of the European nomenclature of territorial units for
statistics: “NUTS 2”).
The dataset was also used to perform a univariate de-
scriptive analysis of in-herd impact of congenital SBV, by
calculating the median and average frequency of defective
offspring.Results
Disease situation
Number of reported congenital SBV-infected herds
From January 2012 to August 2013, 4,810 congenital SBV-
infected herds were reported in France. Among these,
3,348 (70%) were cattle herds, 1,410 (29%) sheep flocks
and 52 (1%) goat flocks (Table 1).
Overall, by August 2013, congenital SBV infection was
reported in 1.5% of the 219,000 cattle farms in France with
cows older than 24 months, 6% of the 23,000 sheep farms
in France with ewes older than 12 months, and 1% of
the 2,000 goat farms in France with goats older than
12 months.
Figure 3 Number of new small ruminant congenital SBV-infected herds reported per month (France, January 2012 – August 2013).
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The first cases of congenital SBV were confirmed in north-
eastern France in late January 2012 in lambs that were born
in early January. The first cases of congenital SBV reported
in goat kids were born in mid-January and the first
cases reported in calves were born in late January.
The number of new reports of congenital SBV-infected
herds per month evolved over two epidemic wavesFigure 4 Number of new cattle congenital SBV-infected herds reporte(Figures 3 and 4). For small ruminants, the first wave
of congenital SBV peaked in February 2012 (with over
600 new infected herds reported that month), and then de-
clined rapidly (Figure 3). For cattle, the first wave peaked
in May 2012 (with about 600 new infected herds reported
that month) and then declined gradually (Figure 4).
The second epidemic wave of congenital SBV began
and peaked about four months earlier than the first: thed per month (France, January 2012 – August 2013).
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in September 2012 (compared to January for the first wave),
and the peak was reached in November for small ruminants
(compared to February for the first wave), and in January
2013 for cattle (compared to May for the first wave)
(Figures 3 and 4).
The two waves of congenital SBV began at the same
period for the different ruminant species (i.e. first wave:
January 2012; second wave: September 2012). How-
ever, the peak occurred about three months later in
cattle than in small ruminants (i.e. first wave: May vs
February respectively; second wave: January vs November
respectively).Spatial patterns of spread
SBV spread rapidly over France from the initial north-
eastern area of detection. All of the regions but two
(Provence-Alpes-Côte d’Azur in south-eastern France and
Corsica) were affected during the first wave (Figure 5).
The magnitude of the outbreak resulting from the first
wave was however much greater in north-eastern France,
where about 85% of the reported congenital SBV-infected
herds were located (Figure 6).
During the second wave, SBV spread further, and
outbreaks were reported throughout France, including
Corsica (Figure 5). The magnitude of the outbreak result-
ing from the second wave was much greater in western
and southern areas, where about 80% of the reported in-
fected herds were located (Figure 6).Figure 5 Number of congenital SBV-infected herds reported by region dImpact assessment
In-herd congenital SBV morbidity rate
In-herd impact investigations were performed in over a
thousand congenital SBV-infected herds from January
to August 2012: 510 infected cattle herds, 612 infected
sheep flocks and 12 infected goat herds were investigated,
accounting respectively for 23%, 48% and 60% of the in-
fected herds reported during this period.
The median frequency of offspring defects (stillborn, or
severely deformed) in the congenital SBV-infected herds
was significantly higher in lambs than in calves (Wilcoxon
test; p =10−16) or kids (Wilcoxon test; p =10−16). On average,
8% of the lambs, 3% of the calves and 2% of the kids that
were born in the congenital SBV-infected herds showed typ-
ical SBV deformities (Table 2). For a given species, there was
a significant variability in the morbidity rate between herds.Deformities observed in the congenital SBV-infected herds
The average frequency of deformities was documented in
almost 3,000 reported congenital SBV-infected herds from
January 2012 to August 2013. For all of the ruminant spe-
cies, arthrogryposis was the most frequent sign reported
in the congenital SBV-infected herds, followed by malfor-
mations of the vertebral column (e.g. stiff neck, scoliosis,
kyphosis) (Figure 7). Arthrogryposis, which was observed
in 94% of the infected sheep flocks, 82% of the infected
cattle herds, and 81% of the infected goat flocks, appears
to be a sensitive criterion on which to form a clinical sus-
picion of congenital SBV disease in ruminants.uring the two epidemic waves (France, January 2012 – August 2013).
Figure 6 Areas of concentration of congenital SBV-infected herds reported over the two epidemic waves (France, January 2012 – August 2013).
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Retrospective farmers’ statements on the unusual occur-
rence of repeated oestrus or early embryonic deaths dur-
ing the 2012 vector season were obtained in 99% of the
congenital SBV-infected herds reported from September
2012 to August 2013. Overall, about 30% of the farmers
stated that during the 2012 vector season they had noticed
more repeated oestrus or early embryonic deaths than
usual (Table 3). This reported frequency was significantlyTable 2 Congenital SBV morbidity in ruminant offspring in re
N = 1,011 herds)
Offspring
species
Offspring born in congenital
SBV-infected herds




Number (N) Median (%) M
Calves 16,338 1,157 7.5 7
Lambs 118,694 18,655 14.0 1
Kids 937 45 6.6 4higher in goat and sheep flocks (44% and 35% respectively)
than in cattle herds (26%) (Fisher exact test; p = 0.04 and
p = 0.02 respectively). In the SBV-infected herds where
more frequent repeated oestrus or early embryonic deaths
than usual had been noticed during the 2012 vector sea-
son, farmers were able to give an estimate of the propor-
tion of females that had been affected: on average, this was
27% of the females in sheep flocks, 15% in cattle herds and




Frequency (n2 over N)
ean (%) Std dev Median (%) Mean (%) Std dev
.1 18.4 480 3.3 2.9 13.0
5.7 30.4 9,311 6.7 7.8 11.8
.8 27.5 16 6.3 1.7 2.6
Figure 7 Average frequency at herd level of disorders encountered in reported congenital SBV-infected herds (France, January 2012 -August
2013, N =1,983 herds).
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Congenital SBV emerged in France during the winter of
2011–2012. A national multi-stakeholder surveillance and
investigation system was promptly implemented to moni-
tor the spread of this new disease, and assess its impact in
ruminant herds. Field data collected from January 2012 to
August 2013 showed that SBV spread rapidly throughout
the country and that congenital SBV morbidity levels were
generally moderate.Spread of SBV epidemic
Number of reported outbreaks
The number of outbreaks of congenital SBV reported
through surveillance provides important indications about
trends in the SBV epidemic but does not provide an accur-
ate estimate of the number of herds that were actually in-
fected by SBV, as some of the SBV-infected herds were
either not detected (i.e. infection of non-pregnant rumi-
nants, infection of pregnant ruminants that were not in
the susceptible stage of gestation) or not reported. Moreover,
under-reporting of congenital SBV may have increased from
September 2012 onwards since SBV was no longer a notifi-
able disease in France, and costs of laboratory analysis for
confirmation were sometimes incurred by the farmers.Table 3 Congenital SBV-infected herds where farmers
retrospectively reported more frequent repeated oestrus
or early embryonic deaths during the 2012 vector season
(France, September 2012 - August 2013, N =1,812 herds)
Species Number of congenital
SBV-infected herds
Number of herds with more
frequent repeated oestrus or
early embryonic deaths
N n %
Cattle 1,509 390 26
Sheep 271 95 35
Goat 32 14 44Temporal patterns of spread
Extrapolation of the estimated dates of foetal infection
from the dates of birth would indicate that the first re-
ported cases of congenital SBV in France in small rumi-
nants in January 2012 must have resulted from infections
that occurred in September or October 2011, while the
first reported cases in calves in January 2012 must have re-
sulted from infections from June to October 2011. This
suggests that the circulation of SBV in France started in
October 2011, at the latest. On the other hand, retrospect-
ive serosurveys carried out in two French departments
(Meurthe-et-Moselle in north-eastern France where con-
genital SBV cases were first confirmed in January 2012,
and Manche in north-western France where congenital
SBV cases were first confirmed in February 2012) showed
that SBV was circulating in these departments in October
2011, while the virus was not detected from serum sam-
ples collected in August or September 2011 [20]. All to-
gether, these data suggest that SBV was not present in
France before September 2011.
The seasonality in the number of reported congenital
SBV-infected herds is consistent with the seasonality in
midge vector activity: each wave of congenital SBV corre-
sponds to cases of congenital SBV resulting from foetal in-
fections that occurred during the previous vector season.
The two waves of congenital SBV started approximately at
the same period for cattle and small ruminants. This ob-
servation is consistent with the minimal interval between
foetal infection and birth, which is estimated to be similar
for the different ruminant species (three months). It is how-
ever noticeable that the epidemic peaked three months later
in cattle than in small ruminants, which is due to the longer
gestation period and the longer time period during which
transplacental infection can lead to foetal damage. The sec-
ond epidemic wave of congenital SBV began and peaked
about four months earlier than the first wave, probably due
to an earlier onset of viral circulation in the vector season
in 2012 (spring) than in 2011 (autumn).
Dominguez et al. BMC Veterinary Research 2014, 10:248 Page 9 of 10
http://www.biomedcentral.com/1746-6148/10/248Spatial patterns of spread
The spatial distribution of congenital SBV incidence rates
cannot be assessed through surveillance, due on the one
hand to the underestimation of the number of infected
herds, and on the other hand to the lack of knowledge of
the number of susceptible herds (i.e. with pregnant rumi-
nants in the susceptible stage of gestation). However,
congenital SBV surveillance data still provide valuable
information on the trends of the epidemic’s spread. The
findings indicate that the virus spread rapidly across north-
eastern France during the first wave. Consistently, serosur-
veys conducted during the spring of 2012 indicated that
SBV within-herd seroprevalence was high in north-eastern
France [21]. In that area, outbreaks of congenital SBV were
reported rather sporadically during the second wave.
Numerous infected herds were identified in southern
and western parts of the territory during the second wave.
Providing that SBV infection results in long-term protect-
ive immunity [12], and despite considerable uncertainty
concerning the level of immunity at the population level in
the infected areas, the epidemic peak of congenital SBV
seems behind us, even if sporadic outbreaks of congenital
SBV resulting from the infection of previously unexposed
animals are still being reported during the third epidemic
wave. As of the 15th of August 2014, 108 congenital SBV-
infected herds had been reported throughout France since
the first of September 2013 during surveillance of the third
wave [22]. Comparatively, 2,976 congenital SBV-infected
herd were reported during thefirst wave, and 1,834 during
the second wave.SBV impact assessment
In the infected herds, SBV impacts were primarily due to
the birth of stillborns or deformed foetuses and neonates.
While all of the abortions or stillbirths observed in the in-
fected herds might not have been due to SBV infection,
congenital deformities known to be fairly specific manifes-
tations of SBV congenital infection represent a valuable
indicator of SBV impact (even if the imputability of SBV
virus in the occurrence of the disorders or deformities
reported has not been ascertained). On average, 8% of the
lambs, 3% of the calves and 2% of the kids born in SBV-
infected herds showed SBV-typical deformities (AHS)s.
This provides a rough estimate of the direct impact of
SBV virus infection, although it should be noted that this
is only based on farmers’ statements, and a potential infor-
mation bias cannot be ruled out.
Such a large scale impact study is so far unique in Europe.
Our estimate of the median morbidity rate in offspring
is consistent with the results of smaller-scale studies
carried out in Belgium [23]. For a given ruminant species,
there is great variability in the morbidity rate of con-
genital SBV that could be influenced by within-herdseroprevalence, husbandry and reproduction practices, etc.,
as shown elsewhere [2].
Although the direct impact of acute SBV infection
on adult ruminants has so far been considered as minor,
some farmers reported decreases in reproductive capability
in the infected herds during the previous vector season,
suggesting a potential impact of acute SBV infection
on reproduction performance (increased proportion of
females returning to oestrus and increased proportion of
non-pregnant females), presumably due to foetal death
caused by SBV infection of naive females in early stages of
gestation. Such observations were also reported by farmers
in the Netherlands [24] and Belgium [25]. Specific studies
are planned to further explore the impact of SBV infection
during the early stages of gestation and to assess whether
the reproductive capability is durably damaged.
Monitoring an emerging disease situation
About half of the SBV outbreaks reported at the European
level as of April 2013 were located in France [12]. That
does not imply that the disease incidence has been higher
in France than in neighbouring countries, but may rather
result from the surveillance of the epidemic spread in
France, which has greatly benefited from the quality of
collaboration across sectors in the framework of the
ESA Platform. Indeed, in the context of SBV emergence,
the ESA Platform proved to be a valuable tool for enhan-
cing stakeholder coordination, building synergy between
disciplines and sectors, and relaying surveillance efforts
over time to make it sustainable.
Conclusion
SBV rapidly spread across France upon its emergence in
the autumn of 2011. After two seasons of SBV circula-
tion, all the regions had been infected. France continues to
monitor congenital SBV outbreaks, and updated informa-
tion is made available online on a regular basis [http://
www.plateforme-esa.fr/]. Outbreaks of congenital SBV
may occur sporadically from now on, unless further epi-
demics occur if the immunity at population level declines.
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